Effects and Awareness of Substandard and Counterfeit Medicines in Indian Scenario

Authors

  • Priyashi Kumari Student, Department of Computer Science and Engineering, Medi-Caps University, Indore
  • B. Gargi Singh Student, Department of Computer Science and Engineering, Medi-Caps University, Indore

Keywords:

Counterfeit medicines

Abstract

In the last decade many cases of counterfeit medicine have been discovered. Studies on privacy and counterfeiting have suggested that up to 20% of all drugs sold in the Indian market are counterfeit. Due to this high counterfeit medication rate the reliability of medical domain is degrading. Drug manufacturers and distributors are increasingly investing in counter-measures, such as traceability and authentication technologies, to try to minimize the impact of counterfeit drugs. In this study, we are presenting an awareness study of counterfeit drugs among different people and how counterfeit medicines are harming human body, and day by day making our body resistant to drugs. The study also focuses on finding a proper solution for counterfeit drugs prevention using block chain technology.

References

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/ HYPERLINK "https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/%20substandard-drugs-are-a-bigger-problem-for-india-than-fakes/

articleshow/69137983.cms?from=mdrccc"] HYPERLINK "https://economictimes.

indiatimes.com/industry/healthcare/biotech/pharmaceuticals/%20substandard-drugs-are-a-bigger-problem-for-india-than-fakes/articleshow/69137983.cms?from=mdrccc"substandard-drugs-are-a-bigger-problem-for-india-than-fakes/article

show/69137983.cms?from=mdrccc.

Hall C. Technology for Combating Counterfeit Medicine. Pathog Glob Health. 2012; 106(2): 73–76p. Google scholar

https://en.wikipedia.org/wiki/Counterfeit_medications

http://www.forbesindia.com/blog/technology/how-blockchain-can-help-fight-counterfeit-drugs-in-india/

Fadlallah R, El-Jardali F, Annan F, et al. Strategies and Systems-Level Interventions to Combat or Prevent Drug Counterfeiting: A Systematic Review of Evidence Beyond Effectiveness. Pharmaceut Med. 2016; 30(5): 263–276p. https://doi.org/10.1007/s40290-016-0156-4

Newton PN, Green MD, Fernandez FM, Day NP, White NJ. Counterfeit Anti-Infective Drugs. Lancet Infect Dis. 2006; 6(9): 602–613p. Google scholar

https://www.pharmaceuticalonline.com/doc/strategies-to-combat-counterfeit-drugs-and-other-pharma-supply-chain-threats-0001

Downloads

Published

2021-02-22

Issue

Vol. 9 No. 2-3 (2020)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.